Abstract:Current microbial cell factory methods for producing chemicals like 2‐phenylethanol (2PE) often face challenges due to product toxicity inhibiting the production process. While traditional batch liquid‐liquid (L‐L) In Situ Product Removal (ISPR) methods were inadequate for industrial scaling, this study demonstrates that continuous selective L‐L ISPR, using the "Fermentation Accelerated by Separation Technology" (FAST) bioreactor, effectively maintains productivity by controlling 2PE concentrations and extending production times. This approach significantly increases output, making the production of inhibiting products more economically feasible. Current microbial cell factory methods for producing chemicals from renewable resources primarily rely on (fed‐)batch production systems, leading to the accumulation of the desired product. Industrially relevant chemicals like 2‐phenylethanol (2PE), a flavor and fragrance compound, can exhibit toxicity at low concentrations, inhibit the host activity, and negatively impact titer, rate, and yield. Batch liquid‐liquid (L‐L) In Situ Product Removal (ISPR) was employed to mitigate inhibition effects, but was not found sufficient for industrial‐scale application. Here, we demonstrated that continuous selective L‐L ISPR provides the solution for maintaining the productivity of de novo produced 2PE at an industrial pilot scale. A unique bioreactor concept called "Fermentation Accelerated by Separation Technology" (FAST) utilizes hydrostatic pressure differences to separate aqueous‐ and extractant streams within one unit operation, where both production and product extraction take place ‐ allowing for the control of the concentration of the inhibiting compound. Controlled aqueous 2PE levels (0.43 ± 0.02 g kg−1) and extended production times (>100 h) were obtained and co‐inhibiting by‐product formation was reduced, resulting in a twofold increase of the final product output of batch L‐L ISPR approaches. This study establishes that continuous selective L‐L ISPR, enabled by FAST, can be applied for more economically viable production of inhibiting products.

Inhibition Control by Continuous Extractive Fermentation Enhances De Novo 2‐Phenylethanol Production by Yeast

Elevated production of the aromatic fragrance molecule, 2-phenylethanol, using Metschnikowia pulcherrima through both de novo and ex novo conversion in batch and continuous modes

Efficient synthesis of 2-phenylethanol from L-phenylalanine by engineered Bacillus licheniformis using molasses as carbon source

Comprehensive investigations of 2-phenylethanol production by high 2-phenylethanol tolerating Meyerozyma sp. strain YLG18

Multilevel metabolic engineering of Bacillus licheniformis for de novo biosynthesis of 2-phenylethanol

Synthesis of 2-phenylethanol by bioconversion in aqueous-organic solvent two-phase system

Enhanced 2-phenylethanol production by newly isolated Meyerozyma sp. strain YLG18 and characterization of its synthetic pathways

Optimal conditions for 2‐phenylethanol production from l‐phenylalanine by Acinetobacter soli ANG344B

Genetic engineering of an industrial yeast Candida glycerinogenes for efficient production of 2-phenylethanol

Highly efficient production of 2-phenylethanol by wild-type Saccharomyces bayanus strain

Hydrophobic microspheres for in situ removal of 2-phenylethanol from yeast fermentation

De novo Synthesis of 2-phenylethanol from Glucose by Metabolically Engineered Escherichia coli

Refactoring Ehrlich Pathway for High-Yield 2-Phenylethanol Production in Yarrowia lipolytica

Metabolic engineering of the oleaginous yeast Yarrowia lipolytica for 2-phenylethanol overproduction

The De Novo Synthesis of 2-Phenylethanol from Glucose by the Synthetic Microbial Consortium Composed of Engineered Escherichia coli and Meyerozyma guilliermondii

Enhanced inhibitor tolerance and increased lipid productivity through adaptive laboratory evolution in the oleaginous yeast Metshnikowia pulcherrima

Identification of the major fermentation inhibitors of recombinant 2G yeasts in diverse lignocellulose hydrolysates

Rapamycin enhanced the production of 2-phenylethanol during whole-cell bioconversion by yeast

Prospecting and engineering yeasts for ethanol production under inhibitory conditions: an experimental design analysis

Unveiling the mechanism of efficient β‐phenylethyl alcohol conversion in wild‐type Saccharomyces cerevisiae WY319 through multi‐omics analysis

Reconstruction of metabolic module with improved promoter strength increases the productivity of 2-phenylethanol in Saccharomyces cerevisiae